Src inhibition potentiates MCL-1 antagonist activity in acute myeloid leukemia.
Hu X, Li L, Nkwocha J, Kmieciak M, Shang S, Cowart LA, Yue Y, Horimoto K, Hawkridge A, Rijal A, Mauro AG, Salloum FN, Hazlehurst L, Sdrimas K, Moore Z, Zhou L, Ginder GD, Grant S.
Hu X, et al. Among authors: ginder gd.
Signal Transduct Target Ther. 2025 Feb 10;10(1):50. doi: 10.1038/s41392-025-02125-x.
Signal Transduct Target Ther. 2025.
PMID: 39924517
Free PMC article.